Authors


Mark Michels, MD

Latest:

Dexamethasone rebuttal: Who should perform intravitreal injections?

In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.




Ashvini Reddy, MD

Latest:

Sustained drug delivery in ophthalmology

Current options, challenges in developing novel therapies.


Paul Hahn, MD, PhD

Latest:

Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic Atrophy

A retina specialist shares his presentation from the 2023 ASRS Annual Meeting, which describes a study comparing the efficacy of 2 FDA-approved treatments for geographic atrophy based on an anchored matching-adjusted indirect comparison of phase 3 trial findings.


Kassi Jackson

Latest:

FDA issues CRL for aflibercept 8 mg from Regeneron Pharmaceuticals

The company announced the Complete Letter Response from the FDA for the Biologics License Application for aflibercept 8 mg is “solely due to an ongoing review of inspection findings at a third-party filler.”


Varun Chaudhary, MD, FRCS(C)

Latest:

Key Retreatment Decisions in the Clinical Trials for Faricimab in nAMD

Dr Varun Chaudhary presents the retreatment decisions during the treat-and-extend phase of the TENAYA and LUCERNE clinical trials in neovascular AMD, focusing on the percentage of patients who maintained, extended, or reduced their treatment interval based on visual and anatomic criteria.


Roche

Latest:

UNCOVERING HIDDEN PREDATORS IN DISEASE

This article is produced by Roche for healthcare professionals and is not intended to provide medical advice and/or treatment guidance. This website is not country-specific and therefore may contain information which is not applicable to your country.


Theodore Leng, MD, MS

Latest:

Natural language processing helps ophthalmologists access data, improves data curation

Knowledge of tools used in data interpretation helps clinicians trust accuracy of findings.


James P. Dunn, MD

Latest:

Successful ocular surgery in patients with chronic uveitis

While operating on a patient with chronic uveitis presents some challenges, there are a few pearls that may increase success.


Judy Kim, MD

Latest:

Perspectives on Loading Dose and Treatment Extension With New Therapies

Experts discuss the approach to loading doses in the context nAMD and DME. Kaiser, MD explains that loading doses may not be necessary based on studies like the CAT study, while he highlights the importance of individualized treatment plans tailored to the specific needs of each patient and the nuances of different retinal diseases.


Jaclyn L. Kovach, MD

Latest:

Is complement therapy the path forward for geographic atrophy?

Clinical benefit of complement inhibition has been demonstrated in clinical trials, but there are possible consequences to consider.


Emily Kaiser

Latest:

FDA approves clobetasol propionate ophthalmic suspension 0.05% from Formosa Pharmaceuticals and AimMax Therapeutics

The approval marks the first new steroid on the ophthalmic market in more than 15 years.


Marc D. de Smet, MD, PhD

Latest:

Adapting medical retina service in COVID-19 era requires careful approach

Minimizing clinic visits, maximizing use of imaging modalities are key


Marlissa Miller

Latest:

ABVC BioPharma announces approved plan for pilot Good Manufacturing Practice (GMP) facility to produce Vitargus

The plan is intended to upgrade Vitagrus’ manufacturing process so that it can ultimately handle the global market supply.



Veena Raiji, MD, MPH

Latest:

Successful treatment of bilateral diffuse Uveal melanocytic proliueration with plasmapheresis

Nonetheless,BDUMP remains a rare condition with fewer than 60 cases documented in literature.


Christopher Or, MD

Latest:

Ultra-widefield imaging: A critical step in uveitis diagnosis and management

A multifaceted evaluation that includes ultra-widefield imaging can reveal new information and influence treatment decisions.


Sally Justus, BA

Latest:

Q&A: The increasing potential of ERG in diagnosing a wide range of eye conditions

Easier, more accessible functional studies have been made possible


Pamela Ann Weber, MD

Latest:

Humanity + technology: Talking to patients about the science and benefits of clinical trials

When we discuss trial participation with patients, we stress that the goal of these studies is to obtain better visual outcomes and ease the treatment burden.


Elana Meer, BA

Latest:

COVID-19 pandemic highlights the power of electronic health records

Electronic health records may be the future of practice management.



Hattie Hayes

Latest:

Outlook Therapeutics receives positive CHMP opinion for bevacizumab for wet age-related macular degeneration

The European Commission is expected to make a decision about the application before the end of June.


David Hutton

Latest:

Diagnosis and management of solar retinopathy

Solar retinopathy is caused by prolonged or high intensity exposure of the fovea centralis to light energy. Suspected cases of solar retinopathy may require urgent referral to an ophthalmologist for diagnosis, and to eliminate treatable causes for central visual disturbance.


Karl G. Csaky, MD, PhD

Latest:

High-resolution multimodal imaging is key in dry AMD therapeutic development, future management

In an attempt to halt the progression of dry AMD and geographic atrophy, the use of high-resolution optical coherence tomography becomes pivotal.


Charles C. Wykoff, MD, PhD

Latest:

Effectiveness Of Pegcetacoplan In Preserving Visual Function In Geographic Atrophy

Dr Charles Wykoff presents the results of a post hoc microperimetry analysis from the OAKS study demonstrating the effectiveness of pegcetacoplan in preserving visual function.


Chirag Jhaveri, MD

Latest:

Clinical Implications of Port Delivery System in Retinal Diseases

Closing out his discussion on the port delivery system in retinal diseases, Chirag Jhaveri, MD, considers how this approach has impacted the treatment landscape.


Jorge Monasterio Bel, MD

Latest:

Vitrectomy: Is higher speed always better?

Physicians should consider hydrodynamic cavitation when performing this procedure.


Modern Retina Staff Reports

Latest:

Poll: Most anticipated emerging therapies in neovascular AMD and DME

A panel of retina specialists review new and emerging treatments in neovascular AMD and DME, highlighting high-dose aflibercept and KSI-301. Which emerging treatments are you most interested in?


Marc de Smet, MD, PhD

Latest:

Pearls for maintaining quality, safety in retina clinics amid a pandemic

To maintain treatment quality and patient and staff safety in the SARS-CoV-2 era, it is important to minimize clinic visits and maximize the use of imaging modalities. In addition, extending treatment intervals with longer-acting agents is key to maximizing safety and patients’ vision outcomes.

© 2024 MJH Life Sciences

All rights reserved.